Respiratory Hypersensitivity Clinical Trial
Official title:
A Multicentre Randomised Placebo-controlled Double-blind Clinical Trial for Evaluation of Safety and Efficacy of Specific Immunotherapy With an Alum.-Adsorbed Allergoid Preparation of House Dust Mite (D. Pteronyssinus) in Patients With Allergic Bronchial Asthma, Rhinitis, Rhinoconjunctivitis
The trial is performed to assess efficacy and safety of the Allergopharma house dust mite allergoid in bronchial asthma.
The rationale for the present study was to demonstrate clinical efficacy and tolerability compared to placebo in a phase III clinical study of pivotal character with a representative number of patients suffering from fully reversible asthma +/- allergic rhinitis. This condition is present in paediatric and adult patients with a shorter history of GINA II and III asthma, who were investigated in this study. ;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03688074 -
Study to Evaluate Tezepelumab on Airway Inflammation in Adults With Uncontrolled Asthma (CASCADE)
|
Phase 2 | |
| Completed |
NCT02162576 -
Asthma Data Innovation Demonstration Project
|
N/A | |
| Completed |
NCT00254956 -
Effects Of Ciclesonide And Beclomethasone On Lens Opacification In Adult Subjects With Moderate To Severe Persistent Asthma
|
Phase 3 | |
| Recruiting |
NCT06272370 -
Individualizing Treatment for Asthma in Primary Care
|
Phase 4 | |
| Recruiting |
NCT03392129 -
Ai Chi Method for Children With Asthma
|
N/A |